According to Globenewswire, BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to technological innovation and healthcare, announced that its board of directors has officially approved the company's new Ethereum-focused financial strategy. This decision marks BGLC becoming the first Nasdaq-listed company to prioritize Ethereum as an exclusive strategic financial asset, and follows the recent inclusion of Ethereum in the US "...
据Globenewswire报道,致力于技术创新与医疗保健的科技公司BioNexus Gene Lab Corp.(纳斯达克股票代码:BGLC)宣布,其董事会已正式批准公司新的以太坊专注型财务战略。此决策标志着BGLC成为首家将以太坊作为战略财务资产独家优先考虑的纳斯达克上市公司,并与近期以太坊被纳入美国“...